Metformin also interacts with the PD-1/PD-L1 checkpoint pair: the degradation of membrane PD-L1 after metformin treatment has been evidenced in breast tumor mice models and confirmed in breast cancer samples of metformin-treated patients [100]. This evidence concerns the gene CD274 and breast cancer.